Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics.
Parkinson's disease is a neurodegenerative disorder characterized by Lewy bodies, a pathological hallmark comprised mostly of aggregated alpha synuclein. Accumulating evidence demonstrates the association of smaller oligomeric aggregates to disease etiology and many therapeutic approaches are a...
Saved in:
Main Authors: | Hemi Dimant, Liya Zhu, Laura N Kibuuka, Zhanyun Fan, Bradley T Hyman, Pamela J McLean |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/dee3e3b4dd7e4f65acf6ea5d3b17cf92 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
by: Gessica Sala, et al.
Published: (2021) -
Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
by: Iosif Pediaditakis, et al.
Published: (2021) -
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro
by: Gessica Sala, et al.
Published: (2021) -
The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
by: Rachel Kelly, et al.
Published: (2021) -
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency
by: Caitriona McLean, et al.
Published: (2009)